Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT07149714

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07149714
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07149714. Allocation not applicable; no masking; primary purpose treatment. Start 2023-02-17 (actual); primary completion 2028-02-17 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI
Acronym
POTOK
Condition
Ischemic Cardiovascular Disease
Condition
Multivessel Coronary Artery Disease
Condition
Coronary Artery Disease
Condition
Cardiogenic Shock
Condition
Acute Heart Failure (AHF)
Condition
Chronic Heart Failure
Intervention (Device)
iVAC 2L
Lead sponsor
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation (class: other government)

Record details

Record id
cardio:ct-nct07149714
Content hash
c0d3dcbe2ceff99c5a0f04641d22edc9f103353ae83e28e8fc3acb18d9375632